Adverse Drug Reactions in Norway: A Systematic Review

Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and...

Full description

Bibliographic Details
Main Authors: Mojtaba Vaismoradi, Patricia A. Logan, Sue Jordan, Hege Sletvold
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/7/3/102
_version_ 1811184962946203648
author Mojtaba Vaismoradi
Patricia A. Logan
Sue Jordan
Hege Sletvold
author_facet Mojtaba Vaismoradi
Patricia A. Logan
Sue Jordan
Hege Sletvold
author_sort Mojtaba Vaismoradi
collection DOAJ
description Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway.
first_indexed 2024-04-11T13:21:22Z
format Article
id doaj.art-5306a80bf986425c992814133d628461
institution Directory Open Access Journal
issn 2226-4787
language English
last_indexed 2024-04-11T13:21:22Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Pharmacy
spelling doaj.art-5306a80bf986425c992814133d6284612022-12-22T04:22:11ZengMDPI AGPharmacy2226-47872019-07-017310210.3390/pharmacy7030102pharmacy7030102Adverse Drug Reactions in Norway: A Systematic ReviewMojtaba Vaismoradi0Patricia A. Logan1Sue Jordan2Hege Sletvold3Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, NorwayFaculty of Science, Charles Sturt University, Bathurst 2795, NSW, AustraliaCollege of Human and Health Sciences, Swansea University, Swansea SA2 8PP, UKFaculty of Nursing and Health Sciences, Nord University, 8049 Bodø, NorwayPrescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway.https://www.mdpi.com/2226-4787/7/3/102adverse drug reactionspatient safetynursingmedicines managementhealthcare providerADR
spellingShingle Mojtaba Vaismoradi
Patricia A. Logan
Sue Jordan
Hege Sletvold
Adverse Drug Reactions in Norway: A Systematic Review
Pharmacy
adverse drug reactions
patient safety
nursing
medicines management
healthcare provider
ADR
title Adverse Drug Reactions in Norway: A Systematic Review
title_full Adverse Drug Reactions in Norway: A Systematic Review
title_fullStr Adverse Drug Reactions in Norway: A Systematic Review
title_full_unstemmed Adverse Drug Reactions in Norway: A Systematic Review
title_short Adverse Drug Reactions in Norway: A Systematic Review
title_sort adverse drug reactions in norway a systematic review
topic adverse drug reactions
patient safety
nursing
medicines management
healthcare provider
ADR
url https://www.mdpi.com/2226-4787/7/3/102
work_keys_str_mv AT mojtabavaismoradi adversedrugreactionsinnorwayasystematicreview
AT patriciaalogan adversedrugreactionsinnorwayasystematicreview
AT suejordan adversedrugreactionsinnorwayasystematicreview
AT hegesletvold adversedrugreactionsinnorwayasystematicreview